Home

Stephen Hoge

CIK 1760669 · President · last filed 2026-07-16

Stephen Hoge is a President who has filed 208 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for MRNA, was dated Jul 16, 2026. Across all open-market trades the lifetime net is −$312.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $229.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$229.45M

Companies

2

Total Filings

208

Lifetime Open-Market Net

-$312.57M

Filer Profile

Reported Address
C/O MODERNA, INC.
200 TECHNOLOGY SQUARE
CAMBRIDGE, MA 02139
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MRNA President 1,541,300 $148.87 $229.45M -$312.57M 167 2026-07-16
Axcella Health Inc. (AXLA) Delisted Director — $0.40 — $0 3 2021-05-24

Recent Filings

208 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-16 MRNA Mixed — -$2.58M EDGAR
2026-07-15 MRNA Notice (144) −53,336 -$3.61M EDGAR
2026-06-17 MRNA Mixed — -$1.72M EDGAR
2026-06-15 MRNA Notice (144) −53,336 -$2.74M EDGAR
2026-06-03 MRNA Mixed +4,794 -$211.8K EDGAR
2026-05-29 MRNA Mixed +1,057 -$46.7K EDGAR
2026-05-18 MRNA Mixed — -$1.56M EDGAR
2026-05-15 MRNA Notice (144) −53,336 -$2.58M EDGAR
2026-03-03 MRNA Mixed +20,570 -$995.9K EDGAR
2026-02-25 MRNA Mixed — -$4.75M EDGAR
Showing 1–10 of 208
Page 1 of 21
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.